Immune checkpoint blockade therapy,which targets T cells to enhance the antitumor immune response,has become a promising treatment for many cancer types1,2.Till
OBJECTIVE To evaluate the p73 gene G4C14-to-A4T14 double nucleotide polymorphism with both increased gastric cancer(GC) risk and different histological subtypes